In praise of ventricular assist devices-mechanical bridge to virtual crossmatch for the sensitized patient

Journal of Heart and Lung Transplantation

Volumn 29, Issue 7, 2010, Pages 728-730

  Ross, Heather ^a   Tinckam, Kathryn ^a   Rao, Vivek ^a   West, Lori J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

HLA antibodies; mechanical circulatory support; sensitization; virtual cross match

Indexed keywords

BORTEZOMIB; LEUKOCYTE ANTIGEN; PANEL REACTIVE ANTIBODY;

ADULT; ASSISTED CIRCULATION; CASE REPORT; EDITORIAL; FEMALE; GRAFT RECIPIENT; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOADSORPTION; LONG TERM CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIZATION;

ANTIBODIES; HEART DISEASES; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNIZATION; TIME FACTORS;

EID: 77953728040     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.02.006     Document Type: Editorial

References (20)

1. Nwakanma L.U., Williams J.A., Weiss E.S., et al. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 84 (2007) 1556-1563
2. Kfoury A.G., Stehlik J., Renlund D.G., et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant 25 (2006) 1277-1282
3. Morales-Buenrostro L.E., Castro R., and Terasaki P.I. A single human leukocyte antigen-antibody test after heart or lung transplantation is predictive of survival. Transplantation 85 (2008) 478-481
4. Tambur A.R., Pamboukian S.V., Costanzo M.R., et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 80 (2005) 1019-1025
5. Kfoury A.G., Renlund D.G., Snow G.L., et al. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant 28 (2009) 51-57
6. Smith J.D., Hamour I.M., Banner N.R., et al. C4d fixing, luminex binding antibodies-a new tool for prediction of graft failure after heart transplantation. Am J Transplant 7 (2007) 2809-2815
7. Kobashigawa J., Mehra M., West L., et al. Consensus conference participants. J Heart Lung Transplant 28 (2009) 213-225
8. Taylor D.O., Yowell R.L., Kfoury A.G., et al. Allograft coronary artery disease: clinical correlation with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 19 (2000) 518-521
9. Wu G.W., Kobashigawa J.A., Fishbein M.C., et al. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 28 (2009) 417-422
10. Stastny P., Lavingia B., Fixler D.E., et al. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation 84 (2007) 738-745
11. Bayliss J., Bailey M., Leet A., et al. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation 86 (2008) 991-997
12. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. http://optn.transplant.hrsa.gov/ar2008/ (accessed March 18, 2010).
13. Noreen H.J., McKinley D.M., Gillingham K.J., et al. Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation. Transplantation 75 (2003) 501-505
14. Speiser D.E., and Jeannet M. Renal transplantation to sensitized patients: decreased graft survival probability associated with a positive historical crossmatch. Transplant Immunol 3 (1995) 330-334
15. Bryan C.F., Shield C.F., Warady B.A., et al. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc 31 (1999) 225-227
16. Segev D.L., Gentry S.E., Warren D.S., et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 293 (2005) 1883-1890
17. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54 (2009) 312-321
18. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009) 2241-2251
19. Kirklin J.K., Naftel D.C., Kormos R.L., et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 29 (2010) 1-10
20. Drakos S.G., Kfoury A.G., Kotter J.R., et al. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant 28 (2009) 838-842